Brain Imaging And Neuroimaging Market
Rising Incidence and Prevalence of Neurological Disorders to Generate a Plethora of Investment Opportunities
Brain Imaging and Neuroimaging Market by Imaging Type, End User & Region - Forecast 2022 - 2032
Brain Imaging and Neuroimaging Market Snapshot (2022-2032)
[291 Pages Report] The global brain imaging and neuroimaging market is expected to be worth US$ 13,166.5 Million by 2022, and is likely to grow at a moderate CAGR of 5.1% between 2022 and 2032, totalling around US$ 21,569.7 Million by 2032.
|
Report Attribute |
Details |
|
Expected Market Value (2022) |
US$ 13,166.5 Million |
|
Anticipated Forecast Value (2032) |
US$ 21,569.7 Million |
|
Projected Growth Rate (2022-2032) |
5.1% CAGR |
The brain imaging and neuroimaging market is primarily driven by factors such as the rising incidence and prevalence of neurological disorders, increased awareness of neurodegenerative diseases, an increase in the number of traumatic brain injuries, and increased applications of brain imaging and neuroimaging in clinical trials.
Rising demand for non-invasive and minimally invasive devices, expanding therapeutic applications of brain imaging and neuroimaging devices, and the expanding healthcare market in emerging economies are all expected to provide growth opportunities for market participants.
Let us know your requirement to get
100% FREE customization
Brain Imaging and Neuroimaging Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)
The global demand for brain imaging and neuroimaging is projected to increase at a CAGR of 5.1% during the forecast period between 2022 and 2032, reaching a total of US$ 21,569.7 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.8%.
The growing prevalence of neurological disorders, the growing geriatric population, and emerging product trends are some of the factors driving market growth. The rising prevalence of neurological disorders, combined with an ageing population that is more prone to developing neurodegenerative diseases such as Parkinson's, Alzheimer's, dementia, epilepsy, and others, are expected to drive growth in brain imaging and neuroimaging market.
Furthermore, the growing global geriatric population is expected to play a significant role in the growth of the studied market because they are more vulnerable to various neurological disorders and injuries as they age, and when combined with new technological advancements, the studied market is forecasted to grow during the projected period. However, a scarcity of skilled professionals is expected to limit the brain imaging and neuroimaging market’s growth over the projected period.
Which are Some Prominent Drivers of Brain Imaging and Neuroimaging Market?
Rising Global Incidence of Brain Cancer to Promote Market Growth
The rising global incidence of brain cancer, combined with rising rates of neurodegenerative disorders, is expected to fuel the growth of the global brain imaging market. The introduction of innovative products by key imaging segment players is also expected to drive the overall brain imaging and neuroimaging market.
Furthermore, increasing road accidents around the world are anticipated to drive the market during the forecast period. One of the drivers expected to increase the revenue of the brain imaging market is technological advancements in imaging techniques and the availability of reimbursement programmes for various types of imaging tests, including brain imaging.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Challenges Faced by the Brain Imaging and Neuroimaging Market?
High Cost of Imaging Techniques to Impede Market Growth
The high cost of imaging techniques is a major impediment to the growth of the global brain imaging and neuroimaging market. Furthermore, one of the market restraints for brain imaging is a dearth of awareness and the absence of scanners in remote areas.
Region-Wise Insights
What Makes the North America the Largest Market for Brain Imaging and Neuroimaging?
Rise in Disease Prevalence Creating Opportunities for Brain Imaging and Neuroimaging manufacturers
Over the forecast period, North America is expected to have the largest market share. The rise in funding for various neurodegenerative disease researches, the rise in disease prevalence and awareness, and the presence of key market players are the major factors contributing to the growth of the studied market. According to the Parkinson's Foundation, approximately one million people in the United States will have Parkinson's disease (PD) by the end of 2020, and nearly 60,000 Americans are diagnosed with Parkinson's disease each year.
Increasing funding is a critical factor in market expansion. Nearly one million people in the United States will have Parkinson's disease (PD) in 2020. According to the same source, approximately 60,000 Americans are diagnosed with Parkinson's disease each year. As a result, the prevalence of Parkinson's disease rises with age, but an estimated 4% of people with the disease are diagnosed before the age of 50.
According to the National Institute of Health, funding for neurodegenerative diseases was USD 4,021 million in 2020, and it is expected to increase to USD 4,110 million in 2021. Rising research funding is expected to attract the majority of the major players, resulting in rapid growth of the market under consideration. Thus, due to the aforementioned reasons, North America is expected to possess 37.8% market share in 2022, registering a CAGR of 5% for Brain Imaging and Neuroimaging market in the assessment period 2022-2032.
Why Western Europe is considered a Lucrative Market for Brain Imaging and Neuroimaging?
Increasing Prevalence of Brain Cancer favouring market growth
Because of the increasing prevalence of brain cancer and neurodegenerative disorders, Western Europe is expected to dominate the overall brain imaging market over the forecast period. Thus, Europe is expected to hold 35.3% of market share for Brain Imaging and Neuroimaging market in 2022.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which is the Dominant End User in the Brain Imaging and Neuroimaging Market?
Hospitals to hold the Lion’s Share in the Brain Imaging and Neuroimaging Market
End-users in the global brain imaging and neuroimaging market include hospitals, ambulatory surgical centres and clinics and diagnostic centres. In 2020, the hospital segment held the largest share of the brain imaging and neuroimaging market. Brain imaging and neuroimaging is a complex process that necessitates the use of expensive and sophisticated devices and equipment typically found in hospitals.
In addition, hospitals receive significantly more patients than small clinics and other end users. Furthermore, brain imaging and neuroimaging impose a significant burden on healthcare facilities in terms of maintenance costs; hospitals, more than other end-users, can bear such costs. As a result, brain imaging and neuroimaging are mostly used in hospitals, which account for the lion's share of this market segment.
Which is the Leading Imaging Type in the Brain Imaging and Neuroimaging Market?
Brain Imaging to have the Highest Demand in the Market
In recent years, the healthcare industry has seen technological advances in medical devices that provide robust services to patients suffering from brain-related diseases. Brain imaging is currently one of the fastest growing segments of the overall imaging market.
Brain imaging is a screening method that allows doctors to analyse the activity and functioning of the nervous system in order to treat various types of neurodegenerative disorders. There are various types of scanners available on the market to provide services in the brain imaging segment. Brain imaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS).
Among these, functional magnetic resonance imaging (fMRI) is well-known for providing detailed information about brain activity by detecting changes in blood oxygenation. Anatomical and functional information about changes in blood flow to specific areas of the brain are also provided by functional magnetic resonance imaging (fMRI). Brain imaging is widely used in the diagnosis of neurodegenerative diseases like Alzheimer's and Parkinsonism, as well as chronic diseases like brain cancer.
Start-Ups for Brain Imaging and Neuroimaging Market
Key startup players in the Brain Imaging and Neuroimaging market are:
- KinePict, based in Budapest, is a medical software company that makes X-ray imaging more powerful and safer. The patented technology of the company extracts motion-related functional information from X-ray image series and displays it as a kinetic image. The additional information obtained aids in the diagnosis of moving organs. Furthermore, by reducing contrast material and X-ray dose, kinetic imaging may make fluoroscopy and angiography safer.
- icometrix, based in Leuven, has created FDA-approved and CE-certified icobrain software. The company claims that its icobrain software allows for a more consistent and personalized understanding of medical images by quantifying the volume of brain structures and abnormalities. This software is critical because brain scans play an important role in the accurate diagnosis and treatment of various disorders.
- Galgo Medical is a Universitat Pompeu Fabra spin-off that creates medical imaging software. It provides low-cost pathways for the development of advanced medical technology solutions. Galgo Medical provides an efficient means of bringing these solutions to the expanding global market. This is made possible by its in-house software development platform, which is designed for rapid prototyping of medical imaging applications.
Market Competition
Key players in the brain imaging and neuroimaging market include Varian Medical Systems, General Electric Company, Siemens AG, Philips Healthcare, and Toshiba Medical Systems, Hitachi Medical systems, Esaote SpA and Sanrad Medical Systems Pvt. Ltd.
- In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, has completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure. It combines Brightly's well-established cloud-based capabilities in key sectors such as education, public infrastructure, healthcare, and manufacturing with Siemens' digital and software expertise in buildings.
- In August 2022, Ernst & Young LLP (EY US) and GE Digital have announced a partnership to assist organisations in transforming their manufacturing operations. The alliance brings together EY US's proven sector expertise and technology consulting services with GE's more than 100 years of manufacturing experience and rich digital technology.
- In June 2022, Toshiba Electronics Europe GmbH, its European sales and marketing subsidiary, announces the extension of its relationship with Farnell, a global distributor of electronic components, products, and solutions known as Farnell in Europe, Newark in North America, and element in Asia Pacific. Farnell will stock more Toshiba products in larger quantities as a result of this agreement, increasing their support of Toshiba's customer supply chain.
- In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon will participate in clinical and technical research programmes, product evaluation projects, and clinical consultations with Varian under this agreement in order to provide clinical expertise and industry perspectives throughout product development.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2022 |
US$ 13,166.5 Million |
|
Market Value in 2032 |
US$ 21,569.7 Million |
|
Growth Rate |
CAGR of 5.1% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Brain Imaging and Neuroimaging Industry Survey
Brain Imaging and Neuroimaging Market by Imaging Type:
- Functional Magnetic Resonance Imaging (fMRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Electroencephalography (EEG)
- Magnetoencephalography (MEG)
- Near Infrared Spectroscopy (NIRS)
Brain Imaging and Neuroimaging Market by End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics and Diagnostic Centers
Brain Imaging and Neuroimaging Market by Region:
- North America Brain Imaging and Neuroimaging Market
- Latin America Brain Imaging and Neuroimaging Market
- Europe Brain Imaging and Neuroimaging Market
- East Asia Brain Imaging and Neuroimaging Market
- South Asia Brain Imaging and Neuroimaging Market
- Oceania Brain Imaging and Neuroimaging Market
- Middle East and Africa Brain Imaging and Neuroimaging Market
Frequently Asked Questions
FMI projects the global brain imaging and neuroimaging market to expand at a 5.1% value CAGR by 2032
The global brain imaging and neuroimaging market is estimated at a market value of US$ 13,166.5 Million
The global brain imaging and neuroimaging market is expected to garner a market value of US$ 21,569.7 Million
North America is expected to possess 37.8% market share in 2022 in the brain imaging and neuroimaging market
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Imaging Type modifications /Innovation
4. Key Success Factors
4.1. Strategic Developments
4.2. Key regulations
4.3. Imaging Type USPs /Technology
4.4. List of Manufacturers and Providers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Increasing R&D Expenditure
5.2. Forecast Factors - Relevance & Impact
5.2.1. New Imaging Type launches
5.2.2. Cost of Imaging Types
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Brain Imaging and Neuroimaging Market Volume (Units) Analysis 2016-2021 and Forecast, 2022-2032
6.1. Historical Market Volume (Units) Analysis, 2016-2021
6.2. Current and Future Market Volume (Units) Projections, 2022-2032
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Brain Imaging and Neuroimaging Market - Pricing Analysis
7.1. Regional Pricing Analysis By Imaging Type
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Brain Imaging and Neuroimaging Market Value Analysis 2016–2021 and Forecast, 2022-2032
8.1. Historical Market Value (US$ Mn) Analysis, 2016–2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by Imaging Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Imaging Types & Services, 2016–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Imaging Type, 2022-2032
9.3.1. Functional Magnetic Resonance Imaging (fMRI)
9.3.2. Computed Tomography (CT)
9.3.3. Positron Emission Tomography (PET)
9.3.4. Electroencephalography (EEG)
9.3.5. Magnetoencephalography (MEG)
9.3.6. Near Infrared Spectroscopy (NIRS)
9.4. Market Attractiveness Analysis By Imaging Type
10. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User , 2016–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Clinics & Diagnostic Centers
10.4. Market Attractiveness Analysis By End User
11. Global Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Imaging Type
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Imaging Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. Rest of Europe
14.3.2. By Imaging Type
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Imaging Type
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.1.4. Rest of East Asia
16.3.2. By Imaging Type
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Imaging Type
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. South Africa
18.3.1.3. Rest of Middle East and Africa
18.3.2. By Imaging Type
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Brain Imaging and Neuroimaging Market Analysis 2016–2021 and Forecast 2022-2032
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Brain Imaging and Neuroimaging Market Analysis
19.2.1. By Imaging Type
19.2.2. By End User
19.3. Canada Brain Imaging and Neuroimaging Market Analysis
19.3.1. By Imaging Type
19.3.2. By End User
19.4. Mexico Brain Imaging and Neuroimaging Market Analysis
19.4.1. By Imaging Type
19.4.2. By End User
19.5. Brazil Brain Imaging and Neuroimaging Market Analysis
19.5.1. By Imaging Type
19.5.2. By End User
19.6. U.K. Brain Imaging and Neuroimaging Market Analysis
19.6.1. By Imaging Type
19.6.2. By End User
19.7. Germany Brain Imaging and Neuroimaging Market Analysis
19.7.1. By Imaging Type
19.7.2. By End User
19.8. France Brain Imaging and Neuroimaging Market Analysis
19.8.1. By Imaging Type
19.8.2. By End User
19.9. Italy Brain Imaging and Neuroimaging Market Analysis
19.9.1. By Imaging Type
19.9.2. By End User
19.10. Spain Brain Imaging and Neuroimaging Market Analysis
19.10.1. By Imaging Type
19.10.2. By End User
19.11. BENELUX Brain Imaging and Neuroimaging Market Analysis
19.11.1. By Imaging Type
19.11.2. By End User
19.12. Russia Brain Imaging and Neuroimaging Market Analysis
19.12.1. By Imaging Type
19.12.2. By End User
19.13. China Brain Imaging and Neuroimaging Market Analysis
19.13.1. By Imaging Type
19.13.2. By End User
19.14. Japan Brain Imaging and Neuroimaging Market Analysis
19.14.1. By Imaging Type
19.14.2. By End User
19.15. South Korea Brain Imaging and Neuroimaging Market Analysis
19.15.1. By Imaging Type
19.15.2. By End User
19.16. India Brain Imaging and Neuroimaging Market Analysis
19.16.1. By Imaging Type
19.16.2. By End User
19.17. ASEAN Brain Imaging and Neuroimaging Market Analysis
19.17.1. By Imaging Type
19.17.2. By End User
19.18. Australia Brain Imaging and Neuroimaging Market Analysis
19.18.1. By Imaging Type
19.18.2. By End User
19.19. New Zealand Brain Imaging and Neuroimaging Market Analysis
19.19.1. By Imaging Type
19.19.2. By End User
19.20. GCC Countries Brain Imaging and Neuroimaging Market Analysis
19.20.1. By Imaging Type
19.20.2. By End User
19.21. Turkey Brain Imaging and Neuroimaging Market Analysis
19.21.1. By Imaging Type
19.21.2. By End User /p>
19.22. South Africa Brain Imaging and Neuroimaging Market Analysis
19.22.1. By Imaging Type
19.22.2. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Imaging Type foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep dive
21.3.1. Varian Medical Systems
21.3.1.1. Overview
21.3.1.2. Imaging Type Portfolio
21.3.1.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.2. General Electric Company
21.3.2.1. Overview
21.3.2.2. Imaging Type Portfolio
21.3.2.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.3. Siemens AG
21.3.3.1. Overview
21.3.3.2. Imaging Type Portfolio
21.3.3.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.4. Philips Healthcare
21.3.4.1. Overview
21.3.4.2. Imaging Type Portfolio
21.3.4.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.5. Toshiba Medical Systems
21.3.5.1. Overview
21.3.5.2. Imaging Type Portfolio
21.3.5.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.6. Hitachi Medical Systems
21.3.6.1. Overview
21.3.6.2. Imaging Type Portfolio
21.3.6.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.7. Easote S.p.A
21.3.7.1. Overview
21.3.7.2. Imaging Type Portfolio
21.3.7.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.8. Sanrad Medical Systems Pvt. Ltd.
21.3.8.1. Overview
21.3.8.2. Imaging Type Portfolio
21.3.8.3. Profitability by Market Segments (Imaging Type/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Brain Imaging and Neuroimaging Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 02: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 03: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 04: Global Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Region
Table 05: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 06: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 07: North America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 08: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 09: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 10: Latin America Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 11: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 12: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 13: Europe Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 14: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 15: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 16: South Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 17: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 18: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 19: East Asia Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 20: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 21: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 22: Oceania Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Table 23: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country
Table 24: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Imaging Type
Table 25: Middle East and Africa Brain Imaging and Neuroimaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Brain Imaging and Neuroimaging Market Volume (in 000' Units) Analysis, 2016-2021
Figure 02: Global Brain Imaging and Neuroimaging Market Volume Forecast (in 000' Units), 2022-2032
Figure 03: Brain Imaging and Neuroimaging Pricing Analysis (US$) Per Imaging Type, By Region, 2021
Figure 04: Brain Imaging and Neuroimaging Pricing Analysis (US$) Per Imaging Type, By Region, 2021
Figure 05: Global Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 06: Global Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 07: Global Brain Imaging and Neuroimaging Market Absolute $ Opportunity, 2022-2032
Figure 08: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By Imaging Type, 2022-2032
Figure 09: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By Imaging Type, 2022-2032
Figure 10: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 11: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By End User, 2022-2032
Figure 12: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By End User, 2022-2032
Figure 13: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 14: Global Brain Imaging and Neuroimaging Market Share Analysis (%), By Region, 2022-2032
Figure 15: Global Brain Imaging and Neuroimaging Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 16: Global Brain Imaging and Neuroimaging Market Attractiveness Analysis by Region, 2022-2032
Figure 17: North America Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 18: North America Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 19: North America Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 20: North America Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 21: North America Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 22: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 23: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 24: North America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 25: Latin America Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 26: Latin America Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 29: Latin America Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 30: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 31: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 32: Latin America Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 33: Europe Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 34: Europe Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 35: Europe Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 36: Europe Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 37: Europe Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 38: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 39: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 40: Europe Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 41: South Asia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 42: South Asia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 45: South Asia Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 46: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 47: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 48: South Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 49: East Asia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 50: East Asia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 53: East Asia Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 54: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 55: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 56: East Asia Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 57: Oceania Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 58: Oceania Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 61: Oceania Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 62: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 63: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 64: Oceania Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 65: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 66: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Brain Imaging and Neuroimaging Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2016-2021
Figure 69: Middle East and Africa Brain Imaging and Neuroimaging Market Value Forecast (US$ Mn), 2022-2032
Figure 70: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by Imaging Type, 2022-2032
Figure 71: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by End User, 2022-2032
Figure 72: Middle East and Africa Brain Imaging and Neuroimaging Market Attractiveness Analysis by Country, 2022-2032
Figure 73: U. S. Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 74: U. S. Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 75: U. S. Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 76: Canada Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 77: Canada Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 78: Canada Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 80: Mexico Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 81: Mexico Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 83: Brazil Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 84: Brazil Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 86: U. K. Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 87: U. K. Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 88: Germany Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 89: Germany Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 90: Germany Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 91: France Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 92: France Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 93: France Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 94: Italy Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 95: Italy Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 96: Italy Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 97: Spain Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 98: Spain Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 99: Spain Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 100: Russia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 101: Russia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 102: Russia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 103: China Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 104: China Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 105: China Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 106: Japan Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 107: Japan Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 108: Japan Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 110: South Korea Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 111: South Korea Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 112: India Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 113: India Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 114: India Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 116: ASEAN Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 117: ASEAN Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 118: Australia Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 119: Australia Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 120: Australia Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 122: New Zealand Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 123: New Zealand Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 125: GCC Countries Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 126: GCC Countries Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 128: Turkey Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 129: Turkey Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Brain Imaging and Neuroimaging Market Value Analysis (US$ Mn), 2022 & 2032
Figure 131: South Africa Brain Imaging and Neuroimaging Market Value Share, By Imaging Type, 2022 (E)
Figure 132: South Africa Brain Imaging and Neuroimaging Market Value Share, By End User, 2022 (E)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
